Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Caverject in Erectile Dysfunction
NCT06768177Enrolling by invitation
- Sponsor
- Policlinico di Bari
- Start
- Apr 2023
- Primary completion
- Nov 2024
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous platelet-rich plasma in erectile dysfunction (ED) (2 arms), sponsored by Policlinico di Bari. Primary endpoint: International Index of Erectile Function at 24 weeks. Started Apr 2023; status: enrolling by invitation.
02
Drugs
autologous platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06768177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06768177.